MedPath

Kallidinogenase

Generic Name
Kallidinogenase
Drug Type
Biotech
CAS Number
9001-01-8
Unique Ingredient Identifier
OT9M1PSK9N

Overview

No overview information available.

Indication

适用于治疗轻至中度急性血栓性脑梗死。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/03/25
Not Applicable
Recruiting
Beijing Tiantan Hospital
2024/04/24
Phase 1
Completed
2024/01/18
Not Applicable
Recruiting
2023/11/18
Not Applicable
Not yet recruiting
Yi Yang
2023/11/15
Not Applicable
Not yet recruiting
2023/10/16
Not Applicable
Not yet recruiting
First Affiliated Hospital, Sun Yat-Sen University
2019/09/25
Phase 4
Completed
2019/07/16
N/A
Completed
2018/02/13
Phase 4
Completed
2016/06/20
Not Applicable
UNKNOWN
Huisheng Chen

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Urinary Kallidinogenase for Injection
国药准字H20052065
化学药品
注射剂
3/9/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.